Ariadne Labs worked with Surgo Ventures and the Post to visualize state by state vaccine distribution.
As governments and industry invest unprecedented resources in discovery and manufacturing COVID-19 vaccines, it is clear that vaccinating everyone in every corner of the globe will require even more. It will require robust delivery systems to make sure the vaccines reach the most vulnerable. And even so, for the foreseeable future, the vaccines will be in very scarce supply.
The Vaccine Delivery team at Ariadne Labs is leveraging years of studying delivery systems to identify problems in vaccine delivery and capture solutions to support health officials and decision makers with tools and evidence to allow them to plan carefully to ensure that vaccines are distributed efficiently and equitably to the people most in need.
The COVID-19 pandemic has also highlighted the need for technical advice and clear, clean data that allow decision makers to understand those who they serve. The Vaccine Delivery team at Ariadne Labs helps gather and expand access to essential data, explain how to interpret and use it, and engage intersectoral leaders to promote equitable vaccine allocation and support the use of data for good.
A collaboration with the New York Times and Surgo Foundation using the Vaccine Allocation Planner to calculate the number of people who will need a vaccine in each state and county — and where you might fit in that line.
When COVID-19 vaccines become available in the US, states will need to allocate them to their highest priority populations. The Vaccine Allocation Planner for COVID-19 helps state and county decision prepare for...
The Center for Global Development and Ariadne Labs have teamed up to better understand how long it will take to develop a COVID-19 vaccine and manufacture it at scale.
Anthony McDonnell, Robert Van Exan, Kalipso Chalkidou, Julie Rosenberg, Rebecca Weintraub, and Prashant Yadav Much of the discussion around society’s ability to return to “normality” after the COVID-19 pandemic has...
Dr. Rebecca Weintraub discusses complications with the COVID-19 vaccine rollout on Fortune's Brainstorm podcast.
Ariadne Labs' Vaccine Allocation Planner highlighted in USA Today
Becker's Hospital Review spotlights Ariadne Labs' Vaccine Allocation Planner.
Washington Post: Covid-19 is devastating communities of color. Can vaccines counter racial inequity?
Senior scientist Kate Miller on states' vaccine distribution plans for vulnerable populations.
Dr. Rebecca Weintraub discusses the variety of COVID-19 vaccines available and under development.
Dr. Rebecca Weintraub comments on equitable vaccine distribution.
Dr. Rebecca Weintraub in National Geographic on how states are allocating COVID-19 vaccines.
Dr. Rebecca Weintraub joins WCVB to discuss vaccine delivery in Massachusetts.
Ariadne Labs and partners hosted the first part of a multi-part online symposium, “Vaccine Allocation and Social Justice,” on Dec. 4 to explore concrete steps that public health leaders can take to dramatically improve...
Kate Miller speaks with CBS Austin on Ariadne Labs' Vaccine Allocation Planner.
Dr. Rebecca Weintraub joins Today, Explained to discuss the challenges ahead in vaccine delivery.
Dr. Atul Gawande joins MSNBC's Morning Joe to discuss COVID-19 vaccines and national planning.
Data-driven tool will help state and county decisionmakers operationalize phased vaccine distribution.
Dr. Rebecca Weintraub on the need for global COVID-19 vaccine initiative.